Raymond James Maintains Outperform on Quidel, Raises Price Target to $155
Raymond James analyst Andrew Cooper maintains Quidel (NASDAQ:QDEL) with a Outperform and raises the price target from $141 to $155.
Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales
Quidel Corporation (NASDAQ:QDEL) reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6…
Quidel Q2 Adj. EPS $0.75 Misses $1.46 Estimate, Sales $176.60M Miss $194.50M Estimate
Quidel (NASDAQ:QDEL) reported quarterly earnings of $0.75 per share which missed the analyst consensus estimate of $1.46 by 48.63 percent. This is a 59.68 percent decrease over earnings of $1.86 per share from the same
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Analyzing Quidel’s Unusual Options Activity
On Wednesday, shares of Quidel (NASDAQ:QDEL) saw unusual options activity. After the option alert, the stock price moved up to $144.4.
Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation And Transitions BNP Business To Beckman Coulter; Co. To Receive Cash Payments $70M-$75M Per Year Through 2029
Settlement Agreement ends litigation that began in November 2017, following Quidel's acquisition of the BNP Business from Alere, Inc. ("Alere")
Quidel to receive cash payments between $70
OraSure Shares Spike Higher; Traders Circulate TradeTheNews Rumor Co Rebuffs Quidel Takeover Offer And Explores Options
https://twitter.com/TrueTraderNet/status/1417164852573835265
Quidel Says State Of Delaware Selects Co For COVID-19 Testing Program At Schools; Terms Not Disclosed
Quidel Corporation (NASDAQ:QDEL) ("Quidel"), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is entering a
Quidel Says Receives CE Mark For Savanna Multiplex Molecular Analyzer And Respiratory Viral Panel
Quidel Corporation (NASDAQ:QDEL) ("Quidel"), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the company has